Capital Markets

MindMed in its $249-million underwritten public offering MindMed in its $249-million underwritten public offering

MindMed
Key Contact
Trevor R. Scott

Partner, Corporate, Vancouver

Team
Minji Park

Partner, Corporate, Vancouver

Julia McCarty

Associate, Corporate, Vancouver

Kim Maguire

Partner, Tax, Vancouver

On November 3, 2025, Mind Med, a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, announced it closed approximately a $249-million underwritten public offering which includes a full exercise of the underwriter’s option to purchase additional shares.

Osler, Hoskin & Harcourt LLP acted as Canadian counsel to MindMed with a team consisting of Trevor Scott, Minji Park and Julia McCarty (Corporate) and Kim Maguire (Tax).

Value
$249 million
Date Announced
November 3, 2025
Lead Office
Vancouver
Key Contact
Trevor R. Scott

Partner, Corporate, Vancouver

Team
Minji Park

Partner, Corporate, Vancouver

Julia McCarty

Associate, Corporate, Vancouver

Kim Maguire

Partner, Tax, Vancouver